NNelo Trade
← Back to Market News
October 16, 2026 at 10:00 AM UTC

SANGAMO THERAPEUTICS, INC issues Regulation FD disclosure

SANGAMO THERAPEUTICS, INC filed an 8-K covering a Regulation FD disclosure. Nelo verified the filing topics against the primary SEC document. This is a company disclosure filed with the SEC, not an SEC enforcement action.

Official source: U.S. Securities and Exchange Commission

Official source published: October 15, 2026 at 09:33 PM UTC

Open official source